Research on human beings saves countless lives, but has at times harmed the participants. To what degree then should government regulate science, and how? The horrors of Nazi concentration camp experiments and the egregious Tuskegee syphilis study led the US government, in 1974, to establish Research Ethics Committees, known as Institutional Review Boards (IRBs) to oversee research on humans. The US now has over 4,000 IRBs, which examine yearly tens of billions ofdollars of research — all studies on people involving diseases, from cancer to autism, and behavior. Yet ethical violations persist. At the same time, critics have increasingly attacked these committees for delaying or blocking important studies. Partly, science is changing, and the current system has not kept up. Since the regulations were first conceived 40 years ago, research has burgeoned 30-fold. Studies often now include not a single university, but multiple institutions, and 40 separate IRBs thus need to approve a single project. One committee might approve a study quickly, while others require major changes,altering the scientific design, and making the comparison of data between sites difficult. Crucial dilemmas thus emerge of whether the current system should be changed, and if so, how. Yet we must first understand the status quo to know how to improve it. Unfortunately, these committees operate behind closed doors, and have received relatively little in-depth investigation. Robert Klitzman thus interviewed 45 IRB leaders and members about how they make decisions. What he heard consistently surprised him. This book reveals what Klitzman learned, providing rare glimpses into the conflicts and complexities these individuals face, defining science, assessing possible future risks and benefits of studies, and deciding how much to trust researchers — illuminating, more broadly, how we view and interpret ethics in our lives today, and perceive and use power.These committees reflect many of the most vital tensions of our time - concerning science and human values, individual freedom, government control, and industry greed. Ultimately, as patients, scientists, or subjects, the decisions of these men and women affect us all.
Format: CONTRIBUTORS: Robert KlitzmanEAN: 9780199364602COUNTRY: United StatesPAGES: WEIGHT: 702 gHEIGHT: 244 cm
PUBLISHED BY: Oxford University Press IncDATE PUBLISHED: 2015-05-14CITY: GENRE: MEDICAL / EthicsWIDTH: 168 cmSPINE:
Book Themes:
Medicine and Nursing, Bioethics
The book succeeds in providing readers with an insight into a system that operates 'at complex intersections of science, politics, sociology, psychology, money and ethics'. Klitzman conveys how making human research safe is a difficult balancing act between the public's eagerness for treatments and the research community's propensity to respond., In this intelligent, rigorous book, Robert Klitzman looks at the morality of morality-at how the bodies set up to protect research subjects can end up injuring us all. This examination of our confused notions of safety, honesty, and transparency demonstrates that none of these is simple, and that in striving toward any one, we easily betray the others. It is a book about how seeking to do the right thing can lead to justice, and about how equally often it fails to
do so., Few institutions in America are as powerful and yet as invisible to the public as scientific Institutional Review Boards (IRBs). In this important, pioneering book, Robert Klitzman details the challenges facing IRBs today and offers concrete proposals about how they might function better tomorrow., In this intelligent, rigorous book, Robert Kiltzman looks at the morality of morality, Protection of participants is an important
Robert Klitzman, MD, is a Professor of Clinical Psychiatry in the College of Physicians and Surgeons and the Joseph Mailman School of Public Health, and the Director of the Masters of Bioethics Program at Columbia University. He has conducted research and written about a variety of bioethical issues, and has authored or co-authored over 100 articles, and seven books, including Am I My Genes?: Confronting Fate and Family Secrets in the Age ofGenetic Testing; When Doctors Become Patients; Mortal Secrets: Truth and Lies in the Age of AIDS; Being Positive; A Year-long Night: Tales of a Medical Internship; The Trembling Mountain: A Personal Account of Kuru, Cannibals, and Mad Cow Disease; and In a House of Dreams and Glass: Becoming a Psychiatrist. His work hasappeared in JAMA, Science, and elsewhere, and also has written for the New York Times, Newsweek, The Nation, and other publications.
Research on human beings saves countless lives, but has at times harmed the participants. To what degree then should government regulate science, and how? The horrors of Nazi concentration camp experiments and the egregious Tuskegee syphilis study led the US government, in 1974, to establish Research Ethics Committees, known as Institutional Review Boards (IRBs) to oversee research on humans. The US now has over 4,000 IRBs, which examine yearly tens of billions ofdollars of research — all studies on people involving diseases, from cancer to autism, and behavior. Yet ethical violations persist. At the same time, critics have increasingly attacked these committees for delaying or blocking important studies. Partly, science is changing, and the current system has not kept up. Since the regulations were first conceived 40 years ago, research has burgeoned 30-fold. Studies often now include not a single university, but multiple institutions, and 40 separate IRBs thus need to approve a single project. One committee might approve a study quickly, while others require major changes,altering the scientific design, and making the comparison of data between sites difficult. Crucial dilemmas thus emerge of whether the current system should be changed, and if so, how. Yet we must first understand the status quo to know how to improve it. Unfortunately, these committees operate behind closed doors, and have received relatively little in-depth investigation. Robert Klitzman thus interviewed 45 IRB leaders and members about how they make decisions. What he heard consistently surprised him. This book reveals what Klitzman learned, providing rare glimpses into the conflicts and complexities these individuals face, defining science, assessing possible future risks and benefits of studies, and deciding how much to trust researchers — illuminating, more broadly, how we view and interpret ethics in our lives today, and perceive and use power.These committees reflect many of the most vital tensions of our time - concerning science and human values, individual freedom, government control, and industry greed. Ultimately, as patients, scientists, or subjects, the decisions of these men and women affect us all.
Format: CONTRIBUTORS: Robert KlitzmanEAN: 9780199364602COUNTRY: United StatesPAGES: WEIGHT: 702 gHEIGHT: 244 cm
PUBLISHED BY: Oxford University Press IncDATE PUBLISHED: 2015-05-14CITY: GENRE: MEDICAL / EthicsWIDTH: 168 cmSPINE:
Robert Klitzman, MD, is a Professor of Clinical Psychiatry in the College of Physicians and Surgeons and the Joseph Mailman School of Public Health, and the Director of the Masters of Bioethics Program at Columbia University. He has conducted research and written about a variety of bioethical issues, and has authored or co-authored over 100 articles, and seven books, including Am I My Genes?: Confronting Fate and Family Secrets in the Age ofGenetic Testing; When Doctors Become Patients; Mortal Secrets: Truth and Lies in the Age of AIDS; Being Positive; A Year-long Night: Tales of a Medical Internship; The Trembling Mountain: A Personal Account of Kuru, Cannibals, and Mad Cow Disease; and In a House of Dreams and Glass: Becoming a Psychiatrist. His work hasappeared in JAMA, Science, and elsewhere, and also has written for the New York Times, Newsweek, The Nation, and other publications.
Dramatiese wisselwerking tussen 'n onderhandelaar en 'n skieter
“Ons het ’n gyselaarsituasie in Stellenbosch.” Blinde kol boei vanaf hierdie openingsin, met ’n spanningslyn wat deurgaans snaarstyf volgehou word. Dit is 2 Oktober 2025 en ’n man het sy pad ingeskiet in ’n dameskoshuis. Hy hou verskeie studente aan en kort-kort klap daar nog skote. Hy vra vir Karla Blanckenberg by die naam, wil spesifiek met háár praat.
Karla onthou dat die skieter, Altus, die seun is wat sy in 2019 oorreed het om nie van ’n dak af spring nie. Die storielyn wissel behendig en ongeforseerd tussen hierdie twee tydgleuwe, ook tussen die voorgeskiedenis van die skieter en dié van Karla.
Benewens die spanningsvolle gebeure, word daar sensitiewe dinge oopgeskryf, soos selfmutilasie. “Ink kan sê hoe sy voel. Maar bloed kan dit ’n ruk lank wegvat.” (p.156) Daar is ook Altus se obsessie met mooi meisies en seks wat hy voel dat hy verdien maar nie kry nie. Daar is baie bloedvergieting, maar Martin Steyn is ’n meester wat dit verteerbaar aanbied, selfs vir ’n redelike sensitiewe leser soos ekself.
Adjudant Karla Blanckenberg en haar spanlid, Adjudant Colin Menck, het verskyn in vroeëre boeke van hierdie skrywer, maar Blinde Kol kan op eie bene staan. Dit is ’n produk van Lapa Uitgewers.
'n Joernalis soek na 'n fonds op 'n roosplaas in Marokko, en ontbloot geheime
Om ’n laaste wens van haar pa te eerbiedig, vertrek Gemma na Marokko, en spesifiek na die roosplaas, Sangrose. Die Marokkaanse landskap daarheen word goed uitgebeeld en verklaar waarom Soet rose, donker geheime, deur Frenette van Wyk uitgegee is as ’n romanse in die Reis sub-genre. Die titel is ook goed gekies, want op die pragtige plaas met duisende roosbome, is daar beslis geheime opgesluit.
Gemma is ’n joernalis met ’n ondersoekende gees. Haar pogings om die geheime te ontbloot, bring haar in uiteindelik in konflik met die eienaar van die plaas, die wewenaar, Julien, terwyl daar vanuit die staanspoor ’n definitiewe aantrekking tussen hulle was.
Die storie herinner my sterk aan Daphne du Maurier se Rebecca, hoewel dit in verskillende tye en plekke afspeel. Dalk is dit die rosetuine, maar veral die antagonis, die hatige Mrs Danvers. In hierdie verhaal is dit Samira wat openlik vyandig is en soos ’n skim verskyn oral waar Gemma beweeg.
Soet rose, donker geheime is ’n publikasie van Lapa Uitgewers onder die Romanza druknaam.
Luke en Lilihanna is lank genoeg in ’n verhouding dat sy al ’n diamantring begin verwag. Drama sommer met die intrapslag: hy verlaat die prentjie op onbedagsame wyse en laat vir Lilihanna verslae agter. Die volgende man wat te voorskyn kom is die skatryk Sebastian. Ek het nie geweet wat om te maak met hierdie karakter nie. Is hy ’n gewillige held of ’n onwaarskynlike held? Of is die held dalk die fotograaf, Leo, met sy lang hare, sy motorfiets en sy byna rebelse aantreklikheid?
Voorkoms staan sentraal in die storielyn. Sebastian, wat ’n reeks haarsalonne en ’n holostiese spa besit waar oormaaksessies aan die orde van die dag is, verras met ’n stelling: “Liefde is die onwerklike opwelling van emosie wanneer jy onverwags daardie één sien, ongeag of hulle nou in aanddrag uitgevat is of in vodde.” (p.31)
Skrywer Beatrix Smith was ook nie haastig om al my vrae te beantwoord nie, en ek gaan dit net so aan lesers oorlaat om te bepaal wié Lilihanna se hart gaan steel. My bestemde beminde is ’n Romanza uit Lapa Uitgewers se stal.